Number of the records: 1  

Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway

  1. SYS0184394
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20221213115558.0
    100
      
    $a 20221114d2022 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway $f Min Yuan ... [et al.]
    215
      
    $c ilustr., aj fareb., grafy, obr.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0184350 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 69, no. 4 (2022), s. 807-819 $1 210 $a Bratislava $c AEPress $d 2022 $1 215 $a s. 747-993
    606
    1-
    $3 sllk_un_auth*d013274 $a nádory žalúdka $2 mesh
    606
    1-
    $3 sllk_un_auth*d011505 $a proteíntyrozínkinázy $x antagonisty a inhibítory $2 mesh
    606
    1-
    $3 sllk_un_auth*d060890 $a antigén B7-H1 $2 mesh
    606
    2-
    $3 sllk_un_auth*d009385 $a procesy nádorové $2 mesh
    606
    2-
    $3 sllk_un_auth*d045744 $a línia bunková nádorová $2 mesh
    606
    2-
    $3 sllk_un_auth*d023041 $a testy protinádorového účinku na xenoimplantátových modeloch $2 mesh
    610
    2-
    $a anlotinib - použitie terapeutické
    610
    2-
    $a expresia PD-L1
    610
    2-
    $a štúdia experimentálna
    701
    -1
    $3 sllk_un_auth*0056971 $a Yuan $b Min $4 070
    801
    -0
    $a SK $b BA006 $c 20221114 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.